Registry Study on "Control Nocturnal Hypertension to Reach the Target "

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

4500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients.

The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks.

Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"

NCT03547856

Hypertension Blood Pressure Cardiovascular Diseases

RECRUITING

Novel BP Monitoring Methods to Study the Association Between Sleep BP Patterns and BP Values in Daily Life

NCT05781256

Ambulatory Blood Pressure Monitoring Home Blood Pressure Monitoring Blood Pressure Determination +1 more

COMPLETED

The Effect of ABPM on Sleep Disturbance

NCT03866226

Blood Pressure Monitoring, Ambulatory

COMPLETED

Management of Uncontrolled Hypertension (HTN)

NCT02922023

Hypertension

TERMINATED NA

Comparisonbetween Primary Hypertension Monitoring Methods for Detection of Early Kidney Dysfunction

NCT03491813

Primary Hypertension

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nocturnal Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nocturnal controlled hypertension

Nocturnal blood pressure was controlled under 120/70 mmHg after aggressive anti-hypertensive therapy.

No interventions assigned to this group

Nocturnal uncontrolled hypertension

Nocturnal blood pressure was still over 120/70 mmHg after aggressive anti-hypertensive therapy.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 50-79 years old
* Clinical diagnosed hypertension with the use of antihypertensive drugs
* Nocturnal hypertension ( nocturnal systolic blood pressure ≥ 130 mmHg and/or nocturnal diastolic blood pressure ≥ 80 mmHg)
* A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.
* Willing to provide information about disease history and blood biochemical test data within 6 months.
* Sign the informed consent